Stock Track | Staar Surgical Soars 15.64% After-Hours on Strong Q1 Earnings Beat and China-Driven Sales Growth

Stock Track05-14 04:33

Staar Surgical's stock surged 15.64% in after-hours trading on Wednesday following the release of its first-quarter financial results, which significantly exceeded analyst expectations.

The intraocular lens maker reported a swing to profitability with Q1 earnings of $0.10 per diluted share, beating the consensus estimate of an $0.05 loss. Revenue more than doubled year-over-year to a record $93.5 million, well above the $78.7 million analysts had forecast. The company attributed the strong performance to a recovery in demand in China, normalization of distributor inventory, and the successful launch of its EVO+ ICL product in the region.

Gross margin improved to 73.6% from 65.8% a year earlier, driven by manufacturing efficiencies and lower costs. Management expressed confidence in consistent, profitable growth for 2026, with plans for its Swiss facility to supply all lenses shipped to China, thereby avoiding import tariffs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147611358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147611358","market":"hk","top_or_hot":-1,"title":"Stock Track | Staar Surgical Soars 15.64% After-Hours on Strong Q1 Earnings Beat and China-Driven Sales Growth","media":"Stock Track","content":"<p>Staar Surgical's stock surged 15.64% in after-hours trading on Wednesday following the release of its first-quarter financial results, which significantly exceeded analyst expectations.</p><p>The intraocular lens maker reported a swing to profitability with Q1 earnings of $0.10 per diluted share, beating the consensus estimate of an $0.05 loss. Revenue more than doubled year-over-year to a record $93.5 million, well above the $78.7 million analysts had forecast. The company attributed the strong performance to a recovery in demand in China, normalization of distributor inventory, and the successful launch of its EVO+ ICL product in the region.</p><p>Gross margin improved to 73.6% from 65.8% a year earlier, driven by manufacturing efficiencies and lower costs. Management expressed confidence in consistent, profitable growth for 2026, with plans for its Swiss facility to supply all lenses shipped to China, thereby avoiding import tariffs.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Staar Surgical Soars 15.64% After-Hours on Strong Q1 Earnings Beat and China-Driven Sales Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Staar Surgical Soars 15.64% After-Hours on Strong Q1 Earnings Beat and China-Driven Sales Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-14 04:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Staar Surgical's stock surged 15.64% in after-hours trading on Wednesday following the release of its first-quarter financial results, which significantly exceeded analyst expectations.</p><p>The intraocular lens maker reported a swing to profitability with Q1 earnings of $0.10 per diluted share, beating the consensus estimate of an $0.05 loss. Revenue more than doubled year-over-year to a record $93.5 million, well above the $78.7 million analysts had forecast. The company attributed the strong performance to a recovery in demand in China, normalization of distributor inventory, and the successful launch of its EVO+ ICL product in the region.</p><p>Gross margin improved to 73.6% from 65.8% a year earlier, driven by manufacturing efficiencies and lower costs. Management expressed confidence in consistent, profitable growth for 2026, with plans for its Swiss facility to supply all lenses shipped to China, thereby avoiding import tariffs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"","article_id":"1147611358","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147611358","pubTimestamp":1778704383,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Staar Surgical's stock surged 15.64% in after-hours trading on Wednesday following the release of its first-quarter financial results, which significantly exceeded analyst expectations.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company"},"translate_title":"个股追踪|Staar Surgical盘后飙升15.64%，因Q1盈利强劲增长和中国推动的销售增长","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1},"content_text":"Staar Surgical's stock surged 15.64% in after-hours trading on Wednesday following the release of its first-quarter financial results, which significantly exceeded analyst expectations.The intraocular lens maker reported a swing to profitability with Q1 earnings of $0.10 per diluted share, beating the consensus estimate of an $0.05 loss. Revenue more than doubled year-over-year to a record $93.5 million, well above the $78.7 million analysts had forecast. The company attributed the strong performance to a recovery in demand in China, normalization of distributor inventory, and the successful launch of its EVO+ ICL product in the region.Gross margin improved to 73.6% from 65.8% a year earlier, driven by manufacturing efficiencies and lower costs. Management expressed confidence in consistent, profitable growth for 2026, with plans for its Swiss facility to supply all lenses shipped to China, thereby avoiding import tariffs.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147611358","isCrawlerRequest":true}